Chemical Structure : Leriglitazone
CAS No.: 146062-44-4
货号: PC-49255Not For Human Use, Lab Use Only.
Leriglitazone (MIN-102) is a novel brain penetrant, selective and orally bioavailable PPARγ agonist with EC50 of 9 uM, shows potential best-in-class profile indicated for CNS diseases.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥1980 | In stock | |
| 10 mg | ¥3280 | In stock | |
| 25 mg | ¥5280 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Leriglitazone (MIN-102) is a novel brain penetrant, selective and orally bioavailable PPARγ agonist with EC50 of 9 uM, shows potential best-in-class profile indicated for CNS diseases.
Leriglitazone (MIN-102) increases frataxin levels and mitochondrial markers in FRDA models.
Leriglitazone (MIN-102) protects from neurodegeneration by improving mitochondrial function.
Leriglitazone (MIN-102) prevents lipid droplets formation in frataxin-deficient cardiomyocytes.
Leriglitazone (MIN-102) rescues the motor function deficit of the YG8sR mice.
Leriglitazone (MIN-102) emerges as a potential therapeutic agent for Friedreich Ataxia.
| 分子量 | 372.439 | |
| 分子式 | C19H20N2O4S | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
5-[[4-[2-[5-(1-Hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione |
|
1. Laura Rodríguez-Pascau, et al. Neurobiol Dis. 2021 Jan;148:105162.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright